AbbVie · 20 hours ago
Finance Lead, US Therapeutics Financial Compliance
AbbVie is a company dedicated to discovering and delivering innovative medicines and solutions that address serious health issues. They are seeking a Finance Lead to provide financial process and analytical support for transparency data related to US Commercial events, ensuring accuracy and compliance with federal reporting requirements.
BiotechnologyFinancial ServicesHealth CareMedicalPharmaceuticalVenture Capital
Responsibilities
Leads and develops the US Commercial Therapeutics & Aesthetics Federal ‘Sunshine’ reporting process, to include collecting, reconciling, and reporting data timely and accurately to present to Senior Finance Leadership and the Office of Ethics and Compliance (OEC) on a quarterly and annual basis
Works cross-functionally with Finance, Legal, OEC, Speaker Program Field Operations, and other applicable stakeholders to provide management with insights and drivers of transparency reporting risks and solutions to mitigate identified risks
Leads and develops the quarterly US Commercial transparency data source (35+) reconciliation program, to include conducting variance analysis and working with team managers to identify and track resolution on applicable transactions/events that are not closed and reconciled timely
Leads the execution of quarterly Speaker Program spot audits. Responsibilities include 1) selecting risk-based samples based on US Commercial governance risk assessments and/or emerging/evolving industry risks, 2) overseeing and reviewing testing work conducted by Senior Analysts, and 3) summarizing testing results to Senior Leadership
Leverages data visualization tools (e.g. Power BI) and/or builds dashboards to support department efforts in enhancing financial metrics reporting, strengthening data integrity, identifying data trends/insights, and/or streamlining current work processes
Collaborating with business stakeholders to complete investigation work and track internal and external audit requests
Root cause analysis on audit findings and/or OEC/Legal identified risks. Develops focused field training as needed
Build strong relationships with peers and cross-functional business partners outside of the team
Qualification
Required
Bachelor's degree in Finance, Accounting, Data Analytics, Statistics, or Business Analytics required
Experience in audit, finance, accounting, and/or compliance
Minimum of 6+ years of progressive experience
Strong financial, analytical, problem-solving and organizational skills
High degree of interpersonal and communication skills to work effectively with internal business units, external parties, and internal support functions
Can learn and grasp concepts quickly and can adapt/change course quickly when necessary
Desire to proactively search out and evaluate business problems and opportunities
Proficient financial system/computer skills including Excel, Power BI (including Power Query), and SAP
Willingness to learn BOT and AI technology
Open to suggestions and experimentation for improvement and willing to learn new concepts and processes
Strong communication skills (verbal and written)
Must be able to work well independently and in a team-oriented environment
Preferred
Master's degree and/or CPA preferred
Benefits
Paid time off (vacation, holidays, sick)
Medical/dental/vision insurance
401(k)
Company
AbbVie
AbbVie is a biopharmaceutical company focused on immunology, oncology, neuroscience, virology, and aesthetics. It is a sub-organization of AbbVie.
H1B Sponsorship
AbbVie has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (273)
2024 (190)
2023 (225)
2022 (284)
2021 (186)
2020 (186)
Funding
Current Stage
Public CompanyTotal Funding
$15B2024-02-27Post Ipo Debt· $15B
2023-03-08Post Ipo Equity· $0.25M
2012-12-20IPO
Leadership Team
Recent News
2026-01-09
2026-01-08
Morningstar.com
2026-01-08
Company data provided by crunchbase